Vasopressors & The Older Patient - The 65 Trial

April 27, 2020 00:22:04
Vasopressors & The Older Patient - The 65 Trial
Critical Care Perspectives in Emergency Medicine
Vasopressors & The Older Patient - The 65 Trial

Apr 27 2020 | 00:22:04

/

Show Notes

Current guidelines for many critical illnesses recommend targeting a MAP of 65 mm Hg, with consideration of higher MAPs in older patients with chronic HTN. Recent literature, however, suggests increased mortality in older patients who are exposed to larger quantities of vasopressor medications.  In this podcast, we do a deep dive into the recently published 65 Trial, which sought to evaluate the effect of permissive hypotension in older patients with vasodilatory hypotension.

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

February 14, 2017 00:29:35
Episode Cover

Surviving Sepsis Campaign 2016 Update

The SSC recently published its new recommendations for the management of sepsis and septic shock.  We discuss the key changes and controversies that you...

Listen

Episode 0

April 28, 2023 00:27:21
Episode Cover

Should We Add Fludrocortisone to Hydrocortisone for Septic Shock?

The use of steroids in patients with sepsis and septic shock has been controversial for decades. At present, the Surviving Sepsis Campaign recommends the...

Listen

Episode 0

April 17, 2019 00:22:01
Episode Cover

Tips for the Renal Transplant Patient

Renal transplants are one of the most common organ transplants worldwide.  Renal transplant patients can quickly succumb to illness and present to the ED...

Listen